Research and Markets (http://www.researchandmarkets.com/research/mlzzbq/the_new_trends_of)
has announced the addition of the "The
New Trends of Global Preclinical Development Outsourcing Market"
report to their offering.
The global preclinical development and toxicology research outsourcing
market will likely experience a CAGR of 7% between 2015 and 2020 and
will reach around $6.8 B by 2020. By then the outsourcing penetration in
preclinical development is expected to reach about 45%.
The New Trends of Global Preclinical Development Outsourcing Market,
provides unique insights into the current development states and the
future growth potentials of the global preclinical development
outsourcing market. The report is designed to reveal the latest
development trends in this market, including the detailed insights of
the new R&D strategies of major pharma companies and R&D-focused biotech
companies on preclinical development and toxicology research and their
outsourcing demands. It also includes the analyses on new technologies
and service models that are currently evolving. Most importantly, the
report contains the in-depth analyses of all positive and negative
factors that might control the future growth directions of the global
preclinical development outsourcing market.
The report provides readers a complete picture of the current state of
the global preclinical development and toxicology research outsourcing
market and a clear insight of its future growth potential. It is a
must-read book to all pharmaceutical and biotechnology companies that
seek preclinical development outsourcing opportunities, the preclinical
development and toxicology research-focused service providers that need
to conceive their future development directions, and venture capital
investors that are looking for investment opportunities in the global
pharmaceutical outsourcing industry.
Key Findings of the Report:
Today all drug companies large or small have realized that they are in
a dilemma situation: The drug R&D cost has been climbing up
exponentially while the output of their R&D effort measured by the
number of new drugs approved each year has remained low.
To realize these goals, a new model of virtually integrated
pharmaceutical operation through networked partnerships has evolved in
As part of the lengthy process of drug discovery and development,
preclinical development, including extensive in vitro pharmacological
property profiling and toxicology studies, plays increasingly
important roles in reducing the attrition rate for clinical
development and overall drug R&D cost.
Primarily driven by drug companies' these strong desires, preclinical
development has undergone dramatic changes in the recent years. New
technologies and R&D methodologies, drug companies' strategies and
focuses, and even new outsourcing models have been constantly evolving.
Today drug discovery CROs without in-depth preclinical development
service capability gradually fall behind.
Although the strong growth of the worldwide demand for preclinical
development and toxicology research services just turns back very
recently, whether this trend will still continue in the foreseeable
future is determined by a number of factors and still remains to see.
To further improve the productivity in their R&D, all drug companies
are expected to still make changes in their R&D strategies, including
their outsourcing strategies, in the near future in particular in
discovery research and preclinical development.
On the positive side, the whole industry is currently focusing on
proof-of-concept study, development and incorporation of biomarkers
into early stage R&D, and development of biologic drugs including
On the negative side, major pharma companies' current main focus has
still been on late stage development.
Overall, although the outsourcing service demand for preclinical
development may still experience fluctuations, all above situations
combined together determine that this market may still experience
positive growth in the near future.
Within the global preclinical development outsourcing market, China is
expected to play more important roles.
For more information visit http://www.researchandmarkets.com/research/mlzzbq/the_new_trends_of